| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |